Results 301 to 310 of about 236,761 (380)

Dapagliflozin effect on functional mitral regurgitation and myocardial remodelling: The DEFORM trial

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Functional mitral regurgitation (FMR) is associated with adverse outcomes in patients with heart failure, and current guideline‐directed medical therapy (GDMT) offers limited efficacy in managing FMR. This study aims to evaluate the therapeutic impact of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in patients with ...
Zhuoshan Huang   +18 more
wiley   +1 more source

Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.

open access: yesJAMA Cardiol
Cunningham JW   +21 more
europepmc   +1 more source

Cardiovascular and Renal Outcomes Following Repeated Naringenin Exposure in Normotensive and Hypertensive Rats. [PDF]

open access: yesPharmaceuticals (Basel)
Dada A   +6 more
europepmc   +1 more source

Atrial natiuretic peptid in normal humans: Hemodynamic and renal effects after single and repeated bolus injection [PDF]

open access: yes, 1989
Ball, P.   +8 more
core  

Clinical characteristics and long‐term outcomes in patients with apical hypertrophic cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims As a special type of hypertrophic cardiomyopathy (HCM), apical HCM (ApHCM) has different clinical characteristics while its nature history and prognosis are not well recognized. We aimed to describe the characteristics and outcomes of ApHCM and identify predictors of adverse outcomes.
Meng Guo   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy